Evaluation of Patient Education in Irritable Bowel Syndrome
1 other identifier
interventional
200
1 country
1
Brief Summary
About 10% of the population in western countries suffer from abdominal pain and change of bowel habits - known as the irritable bowel syndrome. The patients suffer from low quality of life and they are often not well taken care of within the public healthcare system. They often feel frustrated and seek both their family doctors, specialists and alternative medicine for help. Many patients feel they do not know enough about their disease, and the uncertainty may enhance bowel symptoms. We want to evaluate the effect of patient information and education in these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Jan 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2006
CompletedFirst Submitted
Initial submission to the registry
March 21, 2006
CompletedFirst Posted
Study publicly available on registry
March 22, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2008
CompletedDecember 21, 2011
December 1, 2011
2 years
March 21, 2006
December 20, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Quality of life
6 months
Change in Gastrointestinal symptom score
6 months
Secondary Outcomes (2)
Change in health related costs
6 months
Evaluation of further patient needs after education
6 months
Interventions
Patient education group
Eligibility Criteria
You may qualify if:
- A diagnosis of Irritable Bowel Syndrome, verified by the Rome II criteria
- Must be able to participate in a education-group
You may not qualify if:
- Another GI-diagnosis or kind of surgery that may interfere with the symptoms of irritable bowel syndrome
- Serious, untreated psychiatric disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sorlandet Hospital HFlead
- Sykehuset Telemarkcollaborator
- The Hospital of Vestfoldcollaborator
Study Sites (1)
Sorlandet Sykehus HF
Kristiansand, 4633, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jostein Sauar, PhD
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2006
First Posted
March 22, 2006
Study Start
January 1, 2006
Primary Completion
January 1, 2008
Study Completion
January 1, 2008
Last Updated
December 21, 2011
Record last verified: 2011-12